These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19033827)

  • 1. Regadenoson, a novel pharmacologic stress agent for use in myocardial perfusion imaging, does not have a direct effect on the QT interval in conscious dogs.
    Zhao G; Serpllion S; Shryock J; Messina E; Xu X; Ochoa M; Belardinelli L; Hintze TH
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):467-73. PubMed ID: 19033827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
    Posch MI; Kay MD; Harhash AA; Huang JJ; Krupinski EA; Abidov A; McMillan NA; Kuo PH
    J Nucl Med Technol; 2020 Mar; 48(1):73-76. PubMed ID: 31604901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
    Partington SL; Lanka V; Hainer J; Blankstein R; Skali H; Forman DE; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2012 Oct; 19(5):970-8. PubMed ID: 22565239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of body mass index and type of low-level exercise on the side effect profile of regadenoson.
    Salgado-Garcia C; Jimenez-Heffernan A; Lopez-Martin J; Molina-Mora M; Aroui T; Sanchez de Mora E; Ramos-Font C; Rivera de Los Santos F; Ruiz-Frutos C
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1906-1914. PubMed ID: 28547175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
    Zhao G; Messina E; Xu X; Ochoa M; Sun HL; Leung K; Shryock J; Belardinelli L; Hintze TH
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):369-75. PubMed ID: 17577101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of regadenoson stress testing in patients with pulmonary hypertension.
    Moles VM; Cascino T; Saleh A; Mikhova K; Lazarus JJ; Ghannam M; Yun HJ; Konerman M; Weinberg RL; Ficaro EP; Corbett JR; McLaughlin VV; Murthy VL
    J Nucl Cardiol; 2018 Jun; 25(3):820-827. PubMed ID: 27896702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myocardial infarction during regadenoson myocardial perfusion imaging.
    Shah S; Parra D; Rosenstein RS
    Pharmacotherapy; 2013 Jun; 33(6):e90-5. PubMed ID: 23471769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson.
    Noel CV; Krishnamurthy R; Masand P; Moffett B; Schlingmann T; Cheong BY; Krishnamurthy R
    Pediatr Cardiol; 2018 Aug; 39(6):1249-1257. PubMed ID: 29748700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging.
    Cabrera R; Husain Z; Palani G; Karthikeyan AS; Choudhry Z; Dhanalakota S; Peterson E; Ananthasubramaniam K
    J Nucl Cardiol; 2013 Jun; 20(3):336-43; quiz 344-5. PubMed ID: 23430361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST Segment Elevation ECG Changes During Pharmacologic Stress With Regadenoson.
    Qamruddin S; Huang HW; Mehra A; Bonyadlou S; Yoon AJ
    Clin Nucl Med; 2016 Jan; 41(1):62-4. PubMed ID: 26447370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regadenoson.
    Garnock-Jones KP; Curran MP
    Am J Cardiovasc Drugs; 2010; 10(1):65-71. PubMed ID: 20063904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regadenoson: a new myocardial stress agent.
    Al Jaroudi W; Iskandrian AE
    J Am Coll Cardiol; 2009 Sep; 54(13):1123-30. PubMed ID: 19761931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachycardia caused by A2A adenosine receptor agonists is mediated by direct sympathoexcitation in awake rats.
    Dhalla AK; Wong MY; Wang WQ; Biaggioni I; Belardinelli L
    J Pharmacol Exp Ther; 2006 Feb; 316(2):695-702. PubMed ID: 16227469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging.
    Rafiq A; Chughtai T; Ashraf U; Patel Y; Raiszadeh F; Sklyar E; Afshar M; Bella JN; Kamalakkannan G
    Indian Heart J; 2020; 72(4):296-298. PubMed ID: 32861387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is regadenoson an appropriate stressor for MPI in patients with left bundle branch block or pacemakers?
    Thomas GS; Kinser CR; Kristy R; Xu J; Mahmarian JJ
    J Nucl Cardiol; 2013 Dec; 20(6):1076-85. PubMed ID: 24132816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in pharmacologic stress agents: focus on regadenoson.
    Johnson SG; Peters S
    J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect evidence of sympathetic stimulation by regadenoson.
    Farris GR; Hage FG; Kumar V; Iskandrian AE
    J Nucl Cardiol; 2019 Apr; 26(2):684-687. PubMed ID: 29948894
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
    Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R
    Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.